Abiopharma

🔍 Black Jeffrey G. (Executive)

Company: EXAGEN INC. (XGN)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 20,466 shares of Common Stock at $9.79 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 269,026.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.